Biogen Inc. (BIIB) — 8-K Filings

8-K Filings (14)

• 8-K Filing — Apr 29, 2026
• Biogen Inc. Files 8-K for Financial Results — Apr 6, 2026 Risk: low
  Biogen Inc. filed an 8-K report on April 6, 2026, to disclose its results of operations and financial condition. The filing includes various XBRL documents deta
• Biogen Inc. Files 8-K on Financials — Oct 14, 2025 Risk: low
  Biogen Inc. filed an 8-K on October 14, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhib
• Biogen Inc. Files 8-K on Financials — Jul 7, 2025 Risk: low
  Biogen Inc. filed an 8-K on July 7, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits,
• Biogen Inc. Files 8-K on Shareholder Votes and Financials — Jun 23, 2025 Risk: low
  Biogen Inc. filed an 8-K on June 23, 2025, reporting on events that occurred on June 17, 2025. The filing primarily concerns the submission of matters to a vote
• Biogen Inc. Files 8-K: Other Events & Exhibits — May 12, 2025 Risk: low
  Biogen Inc. filed an 8-K on May 12, 2025, reporting an event that occurred on May 6, 2025. The filing pertains to 'Other Events' and includes 'Financial Stateme
• Biogen Inc. Files 8-K on Financials — Feb 12, 2025 Risk: low
  Biogen Inc. filed an 8-K on February 12, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The
• Biogen Inc. Announces Board and Executive Changes — Jan 15, 2025 Risk: medium
  Biogen Inc. announced on January 13, 2025, changes in its board of directors and executive compensation. Specifically, Dr. Al Sandage, Jr. resigned from the Boa
• Biogen Inc. Files 8-K: Director & Officer Changes — Oct 30, 2024 Risk: low
  Biogen Inc. filed an 8-K on October 30, 2024, reporting changes in its board of directors and certain officers, along with updates to compensatory arrangements.
• Biogen Inc. Announces Executive and Board Changes — Sep 12, 2024 Risk: medium
  Biogen Inc. announced on September 11, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and dire
• Biogen Inc. Files 8-K on Material Agreements and Obligations — Aug 14, 2024 Risk: medium
  Biogen Inc. filed an 8-K on August 14, 2024, reporting on events that occurred on August 12, 2024. The filing indicates the entry into and termination of materi
• Biogen Inc. Files 8-K on Financials — Aug 1, 2024 Risk: low
  Biogen Inc. filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibit
• Biogen Inc. Files 8-K: Fiscal Year Change and Shareholder Matters — Jun 25, 2024 Risk: low
  Biogen Inc. filed an 8-K on June 25, 2024, reporting events that occurred on June 20, 2024. The filing indicates a change in the company's fiscal year end to De
• Biogen Files 8-K on Financial Results, Operations — Feb 13, 2024 Risk: low
  Biogen Inc. filed an 8-K on February 13, 2024, to report its results of operations and financial condition. This filing, under the Securities Exchange Act of 19

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX